SCHEMBL61248

SCHEMBL61248

C[Zr]1(C)C2C(=Cc3ccccc32)CCC2=Cc3ccccc3C21

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.36
DRD2 P14416 5/20 0.33
DRD4 P21917 5/20 0.33
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
CYP19A1 P11511 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9099409 0.98 KDM1A (0.35) KDM1ADRD2DRD4CYP11B1CYP11B2
SCHEMBL1949050 0.93 DRD2 (0.32) KDM1ADRD2DRD4CYP11B1CYP11B2
SCHEMBL9222380 0.89 DRD2 (0.33) DRD2DRD4CYP11B1CYP11B2CYP19A1
SCHEMBL7204963 0.84 KDM1A (0.38) KDM1ACYP11B1CYP11B2CYP19A1
SCHEMBL2074643 0.81 KDM1A (0.40) KDM1A
SCHEMBL6355473 0.80 CYP11B1 (0.35) KDM1ACYP11B1CYP11B2
SCHEMBL1924092 0.79 CYP19A1 (0.34) DRD2DRD4CYP11B1CYP11B2CYP19A1
SCHEMBL616008 0.78 KDM1A (0.34) KDM1A
SCHEMBL4453972 0.78 DRD2 (0.35) KDM1ADRD2DRD4CYP11B1CYP11B2
SCHEMBL8572177 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 598 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426638-B2 Addition of aluminium alkyl for improved metallocene catalyst FINA TECHNOLOGY (US) 2005-03-02 EP claimed
US-6410665-B1 POLYMERIZATION COORDINATION CATALYST FOR ALPHA-OLEFIN BASELL POLYOLEFINE GMBH (DE) 2002-06-25 US claimed
EP-0474391-B1 Polyolefins NIPPON OIL CO LTD (JP) 1995-10-25 EP claimed
JP-7033826-A None JP disclosed
JP-3203904-A None JP disclosed
JP-63066206-A None JP disclosed
JP-62121707-A None JP disclosed
JP-62121708-A None JP disclosed
US-20230137384-A1 ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY URIGEN PHARMACEUTICALS, INC. 2023-05-04 US disclosed
EP-2894176-B1 Catalyst composition comprising shuttling agent for regio-irregular multi-block copolymer formation DOW GLOBAL TECHNOLOGIES LLC (US) 2022-06-01 EP disclosed
EP-3893053-A1 PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, CURED FILM, MULTILAYER BODY AND DEVICE FUJIFILM Corporation (JP) 2021-10-13 EP disclosed
EP-0294942-A1 Solid catalyst for polymerizing an olefin MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-12-14 EP disclosed
EP-0287666-A1 PROCESS FOR POLYMERIZING OLEFINS Mitsui Chemicals, Inc. (JP) 1988-10-26 EP disclosed
EP-0285443-A1 Process for producing solid catalyst for polymerization of olefins MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-10-05 EP disclosed
EP-0283164-A2 Cyclo-olefinic random copolymer, olefinic random copolymer, and process for producing cyclo-olefinic random copolymers MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-09-21 EP disclosed
EP-0279863-A1 CATALYST FOR POLYMERIZING ALPHA-OLEFIN AND POLYMERIZATION PROCESS MITSUI CHEMICALS, INC. (JP) 1988-08-31 EP disclosed
EP-0279586-A2 Finely divided aluminoxane, process for producing same and its use MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1988-08-24 EP disclosed
JP-S6366206-A POLYMERIZATION OF OLEFIN MITSUI PETROCHEM IND LTD 1988-03-24 JP disclosed
JP-S62121708-A PRODUCTION OF ALPHA-OLEFIN RANDOM COPOLYMER MITSUI PETROCHEM IND LTD 1987-06-03 JP disclosed
JP-S62121707-A PRODUCTION OF ALPHA-OLEFIN RANDOM COPOLYMER MITSUI PETROCHEM IND LTD 1987-06-03 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230137384-A1 ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY OGFR, ALOX5, PTGS1 KDM1A 3163/4885DRD2 2500/4885DRD4 3873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.